Harmony Biosciences Earning Date (HRMY)

USA |NASDAQ |USD

HRMY Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 8, 2022 Jun 2022 - - $0.24
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 8, 2022 Jun 2022 - - $73.82M

Harmony Biosciences's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 2022.

HRMY Earnings Date & History Chart

HRMY Earnings & Revenue Forecast

HRMY Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 5 $2.60 $1.81 $3.28

HRMY Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 3 $2.84 $2.64 $2.73

HRMY Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 5 $480.04M $440.30M $505.80M

HRMY Earnings Date & Revenue History

HRMY Earnings History

|
Show More
Show More

HRMY Revenue History

|
Show More
Show More

Harmony Biosciences Next Earnings Date & Report

HRMY Next Earnings Date & Report Preview: Jun 2022 (FQ)

HRMY's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 30, 2022.

Harmony Biosciences Previous Earnings Dates & Reports

HRMY Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Harmony Biosciences's previous earnings date was May 9, 2022 for its fiscal quarter ended Mar 31, 2022.

HRMY Previous Earnings Date & Report Recap: Dec 2021 (FY)

Harmony Biosciences's previous annual earnings date was Feb 28, 2022 for its fiscal year ended Dec 31, 2021.

HRMY's earnings per share (EPS) was $0.58, missing the consensus analysts forecast of $0.83 by -30.12% , and higher than the previous year's EPS (Dec 2020) by -1164.22%.

Revenues were $305.44M, better than the forecast of $305.09M by 0.11%, and up by 91.21% from previous year's revenue.

The company reported a net income of $40.26M.

Harmony Biosciences reported a free cash flow of $98.26M for its fiscal year, compared to $-4.99M a year ago.

The company ended the fiscal year with $189.98M in total debt, a decrease of -2.20% compared to the previous year.